News

Josephine Young Named to Law360’s Life Sciences Editorial Board 

Partner Josephine Young has been selected to serve on Law360’s life sciences editorial advisory board. Law360’s editorial boards offer insights from top practitioners and other highly informed sources on how Law360 can improve its coverage. Editorial board members keep section editors apprised of significant trends and cases and provide reporters with a pool of knowledgeable sources. Law360 …

Read more

Megan Raymond Named Vice President of PTAB Bar Association

Megan Raymond was elected Vice President of the PTAB Bar Association at the organization’s 2024 annual conference this month. Founded in 2016, the PTAB Bar Association was formed to “serve as an avenue for constructive dialogue between the bar community, the PTAB, and other stakeholders” at the increasingly active forum to resolve issues of patent validity. Megan …

Read more

Jennifer Wu Elected to AABANY Board of Directors

Jennifer Wu has been elected to the board of directors of the Asian American Bar Association of New York (AABANY), a not-for-profit corporation formed in 1989 to represent the interests of New York Asian American attorneys, judges, law professors, legal professionals, legal assistants, paralegals, and law students.  With more than 1,500 members, AABANY’s mission is …

Read more

Firm Celebrates Official Launch Of Japan Office

Groombridge, Wu, Baughman & Stone LLP celebrated the official opening of its Japan office at two receptions held in Tokyo and Osaka in November and December. Japan-based partner Maxwell “Mac” Fox was joined by U.S. partners Nick Groombridge, Steve Baughman, Eric Stone, Megan Raymond and Josephine Young as the firm hosted colleagues and clients.  The …

Read more

Firm Helps Secure Important Court Win Blocking Idaho Law Banning Gender-Affirming Healthcare for Transgender Youth

Groombridge, Wu, Baughman & Stone LLP, along with the American Civil Liberties Union, the ACLU of Idaho, W/rest Collective; and Paul, Weiss, Rifkind, Wharton & Garrison LLP, secured a preliminary injunction halting the enforcement of Idaho’s HB 71, a law banning gender-affirming healthcare for transgender youth.  The U.S. District Court for the District of Idaho …

Read more

Steve Baughman and Megan Raymond Discuss Novo Nordisk’s PTAB Wins, Featured Among “The Biggest PTAB Developments in 2023,” with Law360

Partners Steven Baughman and Megan Raymond spoke to Law360 about the implications of their PTAB victories for pharmaceutical giant Novo Nordisk and PTAB practice in general. In “The Biggest PTAB Developments In 2023,” published on December 18, the publication highlighted the firm’s successful effort to thwart generic challenges to two patents protecting Novo Nordisk’s blockbuster …

Read more

Founding Partners Nick Groombridge and Jennifer Wu Discuss Starting an Elite IP Firm Away from “Big Law” with Managing IP

Managing IP featured founding partners Nick Groombridge and Jennifer Wu in an article Finding a voice: IP boutique partners reflect on quitting ‘big law’.  Nick and Jennifer spoke about the challenges of starting Groombridge, Wu, Baughman & Stone, working at their own IP boutique and their hopes for their first year. Nick talked about his desire to …

Read more

Firm Secures Significant PTAB Win for Novo Nordisk’s Blockbuster Diabetes and Obesity Treatment Drug

October 2, 2023 – Groombridge, Wu, Baughman & Stone successfully defended Novo Nordisk before the Patent Trial and Appeal Board against Mylan Pharmaceuticals in inter partes review (IPR) proceedings seeking to invalidate two Novo patents relating to its blockbuster semaglutide family of drugs, including Ozempic®, Wegovy®, and Rybelsus® (U.S. Patents Nos. 8,536,122 and 8,129,343).  The …

Read more

Firm Wins a Major Victory on Behalf of Genentech

Groombridge, Wu, Baughman & Stone LLP won a major victory on behalf of Genentech in patent litigation brought by Baxalta, Inc. and Baxalta GmbH (now subsidiaries of Takeda Pharmaceuticals) concerning Genentech’s breakthrough Hemophilia A treatment, HEMLIBRA® (emicizumab-kxwh), which has transformed the lives of thousands of patients.  The U.S. District Court for the District of Delaware …

Read more